Condition
Extracorporeal Membrane Oxygenation Complication clinical trials and research
As of November 12, 2026, Find a Trial lists 19 Extracorporeal Membrane Oxygenation Complication clinical trials that are recruiting, at sites in 16 countries (most in United States (4), Australia (4), Italy (3)). By phase: Phase 3 (2), Phase 2 (2), Phase 2/3 (1). The most active sponsors are Fresenius Medical Care Deutschland GmbH (2), Australian and New Zealand Intensive Care Research Centre (2), University Health Network, Toronto (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 19Clinical trials
- 16Countries
Newest Extracorporeal Membrane Oxygenation Complication clinical trials
All recruiting trials (19)
-
Safety and performance of the Novalung kit and Xenios 2.0 during stationary use for patients on ECMO
This observational study tests whether using the Novalung ultimate kit with Xenios 2.0 (and MultiSupport Ground) helps maintain blood oxygenation in adults on ECMO during hospital stay and ground transport.
-
Using near apneic ventilation with ECMO for severe respiratory distress
This study is testing if a new way of breathing support called near apneic ventilation can help patients with severe respiratory distress on ECMO recover better and faster than the usual care.
-
Using cangrelor to improve outcomes in patients with cardiogenic shock on ECMO
This study is testing if adding a medication called cangrelor can help patients in cardiogenic shock on ECMO have better outcomes while reducing bleeding risks during their treatment.
-
Investigating left ventricle unloading during extracorporeal life support
This study looks at how different methods of relieving pressure on the heart can help patients on a special life support system called VA ECLS, especially those in serious heart trouble.
-
MiniLung petite kit for neonates and infants with severe respiratory or cardiac failure
We will test whether the MiniLung petite kit with the Xenios console safely improves oxygenation, removes CO2, and stabilizes circulation in newborns and young infants (2–8 kg) with severe respiratory or cardiopulmonary failure.
-
RECOMMEND platform testing interventions for adults receiving ECMO
This platform tests whether different treatments, such as liberal versus restrictive red blood cell transfusion strategies, help adults on ECMO survive and need less organ support and hospital resources by day 28.
-
Detecting brain injuries in children on ECMO using portable MRI
This study is testing a portable MRI to see if it can help find brain injuries in children on ECMO support more quickly and accurately.
-
Nafamostat mesilate versus heparin for anticoagulation in ECMO after cardiac surgery
This study will test whether nafamostat mesilate works better than unfractionated heparin for anticoagulation in adults on ECMO after cardiac surgery.
-
Bivalirudin versus heparin for blood thinning during ECMO
This trial tests whether bivalirudin keeps anticoagulation closer to target and reduces clotting or bleeding compared with standard heparin in adults on VA- or VV-ECMO.
-
Comparing Bivalirudin and Heparin for Anticoagulation in ECMO Patients
This study is testing whether Bivalirudin works better than Heparin for preventing blood clots in patients on ECMO while also checking for bleeding risks and costs.
-
Monitoring leg pressure in patients on ECMO to prevent compartment syndrome
This study is testing a new device that continuously checks leg pressure in patients on ECMO to see if it helps prevent serious leg problems better than regular methods.
-
Evaluating Red Blood Cell Transfusion in ECMO Patients
This study is trying to find the best hemoglobin levels for red blood cell transfusions in critically ill patients on ECMO to improve their care and outcomes.
-
Timing of Distal Perfusion to Prevent Limb Ischemia in ECMO Patients
This study tests whether giving a special treatment to improve blood flow in the legs right when symptoms start is better than doing it right at the beginning of heart support for patients with severe heart problems.
-
Evaluating new treatments for acute respiratory failure
This study is testing new treatments for patients with severe breathing problems to see if different ventilation methods can help them survive better in the hospital.
-
Evaluation of the EUROSETS ECMOLIFE SYSTEM for Extracorporeal Life Support
This study is testing the safety and performance of a new life support system in patients who need help with their heart and lungs due to serious conditions.
-
Analyzing outcomes of extracorporeal life support after cardiac surgery
This study looks at how extracorporeal life support helps patients with heart failure after heart surgery to see what factors affect their chances of recovery.
-
VV-ECMO without therapeutic blood thinners for severe respiratory failure
This pilot trial tries running veno-venous ECMO without therapeutic anticoagulants to see if it's safe for adults with ARDS.
-
Evaluating ECMO therapy timing for children with septic shock
This study is testing the best timing for using ECMO therapy in children with severe septic shock to see if it can improve their treatment outcomes.
-
Transplanting patients' own mitochondria to improve heart function after ischemia
This study is testing whether injecting children's own mitochondria into their heart can help improve heart function after a lack of blood flow during ECMO treatment.
Related topics
Quick answers
How many Extracorporeal Membrane Oxygenation Complication clinical trials are recruiting right now?
19, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in United States (4 trials), Australia (4 trials), Italy (3 trials), China (3 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.